EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Advancing Precision Medicine: A Review of the Role of Pharmacogenomics in Personalized Drug Therapy

Amirullah, Hira Malghani, Sameya Ashfaq

Journal of Medical & Health Sciences Review · 27.04.2026 · 3 (2) · 191-204

DOI: 10.65035/nwvrex30 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical & Health Sciences Review, online erschienen am 27.04.2026. Verfasst von Amirullah und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The linkage of artificial intelligence (AI), pharmacogenomics, and bioinformatics is still far from achieving the revolution of precision medicine in healthcare. We designed and carried out an overview study that summarizes findings and text from eight selected studies, resulting in the most important advances, trends, and challenges in the domain of precision medicine. As highlighted by Marques et al. AI-powered predictive models and deep learning approaches improve drug response prediction and drug dosage optimization for each patient. (2024) and Singh et al. (2023). Freeman (2023) and Wang et al. discuss how pharmacogenomics can guide the tailoring of treatments according to genetic variability and clinical outcomes. (2025). Furthermore, bioinformatics allowed for the large-scale analysis of genomic data to ultimately refine medical decision-making, according to Olorunsogo et al. (2024). Structured policy frameworks underpin national initiatives, like that of Qatar, geared at implementing pharmacogenomics research (Bastaki et al., 2024). However, ethical issues, economic limitations, and inequities in access to precision medicine remain daunting challenges. Overall, future directions include expansion of AI-based models, international collaborations, and implementation of standardized protocols for integrating pharmacogenomics to practice. This will be important in order to get the best out of precision medicine, and the attention to ethical and accessibility issues will play a role. This paper provides an account of how AI, pharmacogenomics and bioinformatics can revolutionize personalized personal care while discussing areas to which further research and policy is necessary.

Zitieren

APA

Amirullah, Malghani, H., & Ashfaq, S. (2026). Advancing Precision Medicine: A Review of the Role of Pharmacogenomics in Personalized Drug Therapy. Journal of Medical & Health Sciences Review, 3(2), 191-204. https://doi.org/10.65035/nwvrex30

Vancouver

Amirullah, Malghani H, Ashfaq S. Advancing Precision Medicine: A Review of the Role of Pharmacogenomics in Personalized Drug Therapy. Journal of Medical & Health Sciences Review. 2026;3(2):191-204. doi:10.65035/nwvrex30

BibTeX
@article{Amirullah2026,
  author = {Amirullah and Malghani, Hira and Ashfaq, Sameya},
  title = {Advancing Precision Medicine: A Review of the Role of Pharmacogenomics in Personalized Drug Therapy},
  journal = {Journal of Medical & Health Sciences Review},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {191--204},
  doi = {10.65035/nwvrex30}
}
Kostenlos starten →